Portal de Periódicos da CAPES

Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy

2000; Lippincott Williams & Wilkins; Volume: 31; Issue: 4 Linguagem: Inglês

10.1053/he.2000.6959

1527-3350

Josep M. Llovet, Jordi Bruix, Gregory J. Gores,

Organ Transplantation Techniques and Outcomes

HepatologyVolume 31, Issue 4 p. 1019-1021 EditorialFree Access Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy Josep M. Llovet M.D., Corresponding Author Josep M. Llovet M.D. [email protected] Barcelona-Clínic Liver Cancer (BCLC) Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, SpainBCLC Group, Liver Unit, Hospital Clínic, Villarroel 170, 08036-Barcelona, Catalonia, Spain. fax: (34) 93-4515522===Search for more papers by this authorJordi Bruix, Jordi Bruix Barcelona-Clínic Liver Cancer (BCLC) Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, SpainSearch for more papers by this authorGregory J. Gores, Gregory J. Gores Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MNSearch for more papers by this author Josep M. Llovet M.D., Corresponding Author Josep M. Llovet M.D. [email protected] Barcelona-Clínic Liver Cancer (BCLC) Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, SpainBCLC Group, Liver Unit, Hospital Clínic, Villarroel 170, 08036-Barcelona, Catalonia, Spain. fax: (34) 93-4515522===Search for more papers by this authorJordi Bruix, Jordi Bruix Barcelona-Clínic Liver Cancer (BCLC) Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, SpainSearch for more papers by this authorGregory J. Gores, Gregory J. Gores Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MNSearch for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/he.2000.6959Citations: 142AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Sherman M. Screening for hepatocellular carcinoma. Baillieres Clin Gastroenterol 1999; 13: 623–635. 2 Tang ZY, Yu YQ, Zhou XD. Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s. Semin Surg Oncol 1993; 9: 293–297.MEDLINE 3 Bruix J, Castells A, Bosch J, Feu F, Fuster J, García-Pagán JC, Visa J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018–1022.MEDLINE 4 Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434–1440.MEDLINE 5 Makuuchi M. Surgical treatment for hepatocellular carcinoma. In: V Arroyo, J Bosch, J Rodés eds. Treatments in Hepatology. Barcelona: Masson. 1995; 341–352. 6 Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso M del C, Sala M, Bru C, et al. Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62–67.MEDLINE 7 Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular cancer in Japan. The Liver Cancer Study Group of Japan. Cancer 1994; 74: 2772–2780.MEDLINE 8 Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996 13; 334:1561–1567 . 9 Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999; 353: 797–801.MEDLINE 10 Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221–228.MEDLINE 11 Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270–285.MEDLINE 12 Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg 1993; 218: 145–151.MEDLINE 13 Mor E, Tur Kaspa R, Sheiner P, Shwartz ME. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129: 643–653.MEDLINE 14 Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311–322.MEDLINE 15 Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, et al. Liver transplantation for treatment of small hepatocellular carcinoma: the TNM classification does not have prognostic power. Hepatology 1998; 27: 1572–1577.MEDLINE 16 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693–699.MEDLINE 17 Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, Wiesner RH, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999; 5: 192–199.MEDLINE 18 Memoria de la actividad de donación y transplante 1997. Organizacíon Nacional de Transplantes. Centro de Publicaciones del Ministerio de Sanidad y Consumo. 19 United Network for Organ Sharing. Annual report 1998. http://www.unos.org/data. 20 Pereira SP, Williams R. Limits to liver transplantation in UK. Gut 1998; 42: 883–885.MEDLINE 21 Stone MJ, Klintmalm GB, Polter D, Husberg BS, Mennel RG, Ramsay MA, Flemens ER, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104: 196–202.MEDLINE 22 Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163: 387–394.MEDLINE 23 Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, Perrin H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688–701.MEDLINE 24 Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1172–1177.MEDLINE 25 Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1339–1341.MEDLINE 26 Llovet JM, Mas X, Aponte J, Fuster J, Navasa M, Bruix J. BCLC Group. Radical treatment of hepatocellular carcinoma during the waiting list for orthotopic liver transplantation: a cost-effectiveness analysis on an intention-to-treat basis [Abstract] Hepatology 1999; 30(Suppl): 223A. 27 Majno P, Sarasin F, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome oriented decision analysis. Hepatology 2000; 31: 899–906.MEDLINE 28 Wright JC, Weinstein MC. Gains in life expectancy from medical interventions—standardizing data on outcomes. N Engl J Med 1998; 339: 380–386.MEDLINE 29 Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146: 473–481.MEDLINE 30 Majno PE, Adam R, Mazzaferro V, Regalia E, Metha G, Morel PH, Bismuth H. Liver transplantation for recurrence after resection of solitary hepatocellular carcinoma [Abstract] (A) Liver Transpl Surg 1999; 5: S18–S67. Citing Literature Volume31, Issue4April 2000Pages 1019-1021 ReferencesRelatedInformation